| Corinne E Cambio, MD | |
|
100 Hitchcock Way, Manchester, NH 03104 | |
| (603) 650-5922 | |
| Not Available |
| Full Name | Corinne E Cambio |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 22 Years |
| Location | 100 Hitchcock Way, Manchester, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083763429 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 044857 (Connecticut) | Secondary |
| 207L00000X | Anesthesiology | 16630 (New Hampshire) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Care Group Pc | 5395646178 | 62 |
News Archive
Marking World No Tobacco Day on 31st May, the Union for International Cancer Control (UICC) urges governments around the world to reduce tobacco-related cancer deaths and other diseases by increasing investment in tobacco control.
Some of the first analyses on the impact of Medicare Part D, as well as new insights on drug adherence patterns by chronic disease patients, will be presented today and tomorrow at the 2010 Academy/Health Annual Meeting by several University of Maryland, Baltimore teams of pharmaceutical health services researchers.
Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented today at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D., principal investigator of the trial in the United States.
› Verified 6 days ago
| Entity Name | Anesthesia Care Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629074224 PECOS PAC ID: 5395646178 Enrollment ID: O20040115000446 |
News Archive
Marking World No Tobacco Day on 31st May, the Union for International Cancer Control (UICC) urges governments around the world to reduce tobacco-related cancer deaths and other diseases by increasing investment in tobacco control.
Some of the first analyses on the impact of Medicare Part D, as well as new insights on drug adherence patterns by chronic disease patients, will be presented today and tomorrow at the 2010 Academy/Health Annual Meeting by several University of Maryland, Baltimore teams of pharmaceutical health services researchers.
Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented today at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D., principal investigator of the trial in the United States.
› Verified 6 days ago
| Entity Name | Amoskeag Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104883511 PECOS PAC ID: 1759375983 Enrollment ID: O20040513001385 |
News Archive
Marking World No Tobacco Day on 31st May, the Union for International Cancer Control (UICC) urges governments around the world to reduce tobacco-related cancer deaths and other diseases by increasing investment in tobacco control.
Some of the first analyses on the impact of Medicare Part D, as well as new insights on drug adherence patterns by chronic disease patients, will be presented today and tomorrow at the 2010 Academy/Health Annual Meeting by several University of Maryland, Baltimore teams of pharmaceutical health services researchers.
Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented today at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D., principal investigator of the trial in the United States.
› Verified 6 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
Marking World No Tobacco Day on 31st May, the Union for International Cancer Control (UICC) urges governments around the world to reduce tobacco-related cancer deaths and other diseases by increasing investment in tobacco control.
Some of the first analyses on the impact of Medicare Part D, as well as new insights on drug adherence patterns by chronic disease patients, will be presented today and tomorrow at the 2010 Academy/Health Annual Meeting by several University of Maryland, Baltimore teams of pharmaceutical health services researchers.
Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented today at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D., principal investigator of the trial in the United States.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Corinne E Cambio, MD 100 Hitchcock Way, Manchester, NH 03104 Ph: (603) 650-5922 | Corinne E Cambio, MD 100 Hitchcock Way, Manchester, NH 03104 Ph: (603) 650-5922 |
News Archive
Marking World No Tobacco Day on 31st May, the Union for International Cancer Control (UICC) urges governments around the world to reduce tobacco-related cancer deaths and other diseases by increasing investment in tobacco control.
Some of the first analyses on the impact of Medicare Part D, as well as new insights on drug adherence patterns by chronic disease patients, will be presented today and tomorrow at the 2010 Academy/Health Annual Meeting by several University of Maryland, Baltimore teams of pharmaceutical health services researchers.
Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented today at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D., principal investigator of the trial in the United States.
› Verified 6 days ago
Rebecca Elizabeth Kadish, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500 | |
Sean E Hunt, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500 | |
Dr. Charles Beck Eastwood, M.D., C.M. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Elliot Way, Suite 200, Manchester, NH 03103 Phone: 603-663-2315 | |
Alan Mekler, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Elliot Way, Suite 200, Manchester, NH 03103 Phone: 603-663-2315 Fax: 603-647-9180 | |
Dennis L Kelly, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 88 Mcgregor St, Ste 303, Manchester, NH 03102 Phone: 603-647-9325 Fax: 603-647-2453 | |
Martin Leonard Ginsberg, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1 Elliot Way, Suite 200, Manchester, NH 03103 Phone: 603-663-2315 Fax: 603-647-9180 |